Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
82.33
-0.49 (-0.59%)
May 29, 2026, 4:00 PM EDT - Market closed
Zimmer Biomet Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,409 | 8,232 | 7,679 | 7,394 | 6,940 | 6,827 | |
Revenue Growth (YoY) | 9.23% | 7.20% | 3.85% | 6.55% | 1.65% | 11.42% |
Cost of Revenue | 2,520 | 2,494 | 2,191 | 2,084 | 2,020 | 1,960 |
Gross Profit | 5,889 | 5,738 | 5,487 | 5,310 | 4,920 | 4,867 |
Selling, General & Admin | 3,348 | 3,257 | 2,930 | 2,839 | 2,762 | 2,843 |
Depreciation & Amortization Expenses | 676.9 | 665.9 | 591.9 | 561.5 | 526.8 | 529.5 |
Research & Development | 451.3 | 458.5 | 437.4 | 458.7 | 406 | 435.8 |
Other Operating Expenses | 230.5 | 258.1 | 242.6 | 173.6 | 529.6 | 197.9 |
Total Operating Expenses | 4,707 | 4,640 | 4,202 | 4,033 | 4,224 | 4,007 |
Operating Income | 1,179 | 1,098 | 1,286 | 1,278 | 696.3 | 860.3 |
Interest Expense | -295.4 | -292.8 | -218 | -201.2 | -164.8 | -208.4 |
Other Non-Operating Income (Expense) | 22.6 | 25.5 | -31.1 | -9.3 | -128 | -152.9 |
Total Non-Operating Income (Expense) | -272.8 | -267.3 | -249.1 | -210.5 | -292.8 | -361.3 |
Pretax Income | 903.1 | 830.8 | 1,037 | 1,067 | 403.5 | 499 |
Provision for Income Taxes | 142.3 | 125.7 | 131.4 | 42.2 | 112.3 | 53.5 |
Net Income | 761.1 | 705.1 | 903.8 | 1,024 | 231.4 | 401.6 |
Minority Interest in Earnings | -0.4 | -0.1 | 1.5 | 1.1 | 1 | 0.5 |
Earnings From Discontinued Operations | - | - | - | - | -58.8 | -43.4 |
Net Income to Common | 761.1 | 705.1 | 903.8 | 1,024 | 231.4 | 401.6 |
Net Income Growth | -16.67% | -21.98% | -11.74% | 342.52% | -42.38% | - |
Shares Outstanding (Basic) | 197 | 198 | 203 | 209 | 210 | 209 |
Shares Outstanding (Diluted) | 198 | 199 | 204 | 210 | 210 | 210 |
Shares Change (YoY) | -2.23% | -2.55% | -2.77% | -0.29% | -0.05% | 1.64% |
EPS (Basic) | 3.87 | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 |
EPS (Diluted) | 3.85 | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 |
EPS Growth | -14.82% | -19.86% | -9.22% | 343.64% | -42.41% | - |
Shares Outstanding | 193.4 | 195.5 | 199.1 | 205.6 | 209 | 209 |
Free Cash Flow | 1,214 | 1,172 | 1,055 | 978.8 | 910 | 987.1 |
Free Cash Flow Growth | 3.56% | 11.07% | 7.82% | 7.56% | -7.81% | 40.07% |
Free Cash Flow Per Share | 6.14 | 5.90 | 5.18 | 4.67 | 4.33 | 4.69 |
Dividends Per Share | 0.960 | 0.960 | 0.960 | 0.960 | 0.960 | 0.960 |
Gross Margin | 70.03% | 69.71% | 71.46% | 71.82% | 70.90% | 71.29% |
Operating Margin | 14.02% | 13.34% | 16.74% | 17.28% | 10.03% | 12.60% |
Profit Margin | 9.05% | 8.57% | 11.79% | 13.86% | 4.20% | 6.53% |
FCF Margin | 14.43% | 14.24% | 13.74% | 13.24% | 13.11% | 14.46% |
EBITDA | 2,288 | 2,192 | 2,282 | 2,229 | 1,623 | 1,798 |
EBITDA Margin | 27.21% | 26.63% | 29.72% | 30.15% | 23.38% | 26.34% |
EBIT | 1,179 | 1,098 | 1,286 | 1,278 | 696.3 | 860.3 |
EBIT Margin | 14.02% | 13.34% | 16.74% | 17.28% | 10.03% | 12.60% |
Effective Tax Rate | 15.76% | 15.13% | 12.68% | 3.95% | 27.83% | 10.72% |